about
Vision loss among diabetics in a group model Health Maintenance Organization (HMO).Estimates of incidence rates with longitudinal claims data.Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort.Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data.Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.High failure rate associated with 180 degrees selective laser trabeculoplasty.Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis.Resource use and costs associated with diabetic macular edema in elderly persons.One-year outcomes after retinal detachment surgery among medicare beneficiaries.Health literacy and ophthalmic patient education.Practice characteristics and HMO enrollee satisfaction with specialty care: an analysis of patients with glaucoma and diabetic retinopathyMonitoring visual status: why patients do or do not comply with practice guidelines.Visual acuity following cataract surgeries in relation to preoperative appropriateness ratings.Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degenerationProposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.Longitudinal trends in resource use in an incident cohort of open-angle glaucoma patients: resource use in open-angle glaucomaLongitudinal analysis of the relationship between regular eye examinations and changes in visual and functional status.Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease.A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.Despite 'welcome to Medicare' benefit, one in eight enrollees delay first use of part B services for at least two years.Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis.Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005.Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.Association of vitamin D deficiency and age-related macular degeneration in medicare beneficiaries.Longitudinal incidence of adverse outcomes of age-related macular degeneration.Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiariesThe influence of health literacy level on an educational intervention to improve glaucoma medication adherence.Literacy and informed consent: a case for literacy screening in glaucoma research.Development of a vision-targeted health-related quality of life item measure.Surveillance of disparities in vision and eye health in the United States: an expert panel's opinionsHealth literacy and vision-related quality of life.Measuring access to eye care: a public health perspective.Associations of eye diseases and symptoms with self-reported physical and mental health.Understanding the importance of IOP variables in glaucoma: a systematic review.Assessing the Importance of IOP Variables in Glaucoma Using a Modified Delphi Process.The cost of visual impairment: purposes, perspectives, and guidance.Systematic review of educational interventions to improve glaucoma medication adherence.
P50
Q30801318-B7CFA9AF-BF27-4146-A19B-96D21DD5F53AQ30882163-97F90A59-89A6-4F52-B23A-C58425F0E90DQ31029490-109F3D2F-DE5C-4E99-BDE6-5487065DEB07Q31101525-634CF808-3C41-4253-BC05-6E00F8596DF9Q31132387-1D26328B-9413-4512-8809-5640F3FED23CQ33222958-83FE9A49-23CB-4D98-939D-39C698000EF0Q33294215-7F6D785B-4E1E-46F2-99EE-3EF922899573Q33390920-A219E317-B886-457D-82F0-6F4F5F1B932EQ33622103-729C2006-14F4-4BB9-A3F0-FB110F311441Q34054350-56E5C925-64E0-42AC-8A9F-84EE228A26D2Q34335984-ACA6051A-AD1B-42D4-8C22-4FF0B8FC2670Q34336807-38DAFC6F-B88E-4AAE-B9C2-4D7BC6A86A15Q35106562-FAD3EFF2-B0FE-4868-9B99-33309B950060Q35127099-4A2E4171-9B29-4DA0-AF43-40E2BF49F660Q35226427-1504F04B-44FA-497C-A59B-A16E35834B69Q35915939-AA40EF34-5962-40F3-B16E-CE51DBE10FFBQ36074252-A2A0220E-2E25-4706-9D10-082F8E5E35D6Q36173758-07675BAC-E449-469E-BC45-D6C332DC770DQ36307896-04C84350-2644-47BE-A961-685BB9133661Q36357395-41C260F0-A030-49D5-811F-C943FB5A6FA7Q36364306-DC5A8257-D9A8-4F7F-BE45-F2C1E528A5E0Q36429504-195C6010-B325-4F7D-93D4-52F519CDEA90Q36469786-2E98F127-5251-4F28-A627-6E37861E1E36Q36621663-402F48A5-F790-432E-9BDB-08E7B9A5FF73Q36626466-E1A1ACA1-E628-437C-83BE-8DDAE4722F5BQ36740561-D49A83B2-BFB2-411A-AADC-D1EFA3F04E9BQ36740565-C89B1BC9-4DAE-412E-A4DE-D11E6FBC1864Q36753960-596028F0-8C8C-4DA0-B320-AA8B1BCB469EQ36791356-6CC62752-241C-44EA-94A1-4BBBC987A931Q36990641-C1663FE7-6D94-48EA-9012-A31012216D6CQ36990705-6D9C70A1-503A-4CA2-9346-BD731636F186Q37042970-2EDCD3C2-D0B4-454C-B238-A92CBB3B2E0CQ37139310-A8B8575F-9A86-44FF-88D1-8A5506F1F4AEQ37156103-E4D0855A-9F15-4F68-86C4-82C34A9756E4Q37344252-745D0AE0-DB6B-459B-9CF2-9004295D0DC7Q37439533-78B720A5-8E87-418C-B4F1-9001C2C3744AQ37576617-3092E962-8C01-4CCD-9FA5-59E8F4246305Q37621229-26C55275-E13C-4EFD-B37F-585579008E3BQ37673584-666EDA3B-E1F2-460B-87A0-5E6CB16EAF4BQ37711161-039D6BC4-E787-4CDD-8ED8-FAD35180E4BF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Paul P. Lee
@ast
Paul P. Lee
@en
Paul P. Lee
@es
Paul P. Lee
@sl
type
label
Paul P. Lee
@ast
Paul P. Lee
@en
Paul P. Lee
@es
Paul P. Lee
@sl
prefLabel
Paul P. Lee
@ast
Paul P. Lee
@en
Paul P. Lee
@es
Paul P. Lee
@sl
P214
P244
P106
P1153
7406119471
P21
P213
0000 0003 8231 6123
P214
P244
P31
P496
0000-0002-3338-136X
P735
P7859
lccn-n93802134